[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]
Fırat Tıp Dergisi
2020, Cilt 25, Sayı 3, Sayfa(lar) 130-134
[ Turkish ] [ Tam Metin ] [ PDF ]
Are There Clinical, Pathological, Metabolic, and Prognostic Differences Between Cavitary and Non-Cavitary Lung Cancer?
Coşkun DOĞAN1, Nesrin KIRAL1, Elif TORUN PARMAKSIZ1, Banu SALEPÇİ2, Benan ÇAĞLAYAN3, Ali FİDAN1, Sevda CÖMERT ŞENER1
1Kartal Dr Lütfi̇ Kirdar Eği̇ti̇m ve Araştirma Hastanesi, Göğüs Hastaliklari Kliniği, İstanbul, Türkiye
2Yeditepe Üniversitesi Tip Fakültesi, Göğüs Hastaliklari Anabilim Dali, İstanbul, Türkiye
3Koç Üniversitesi Tip Fakültesi, Göğüs Hastaliklari Anabilim Dali, İstanbul, Türkiye

Objective: Our study was planned to investigate the clinical, radiometabolic (PET-CT), and survival properties of primary lung cancer with cavitary.

Material and Method: The files of patients diagnosed as primary lung cancer in our clinic between 2014 and 2016 were examined. The cases were divided into two groups as primary lung cancer with cavity and without cavity. Demographic, radiological, clinical, radiometabolic and survival properties of both groups were recorded. The data of both groups were compared with each other.

Results: A total of 323 cases with a mean age of 61.6 ± 9.8 years were included in the study. There were 36 primary lung cancer cases with and 287 lung cancer cases without cavity. The rate of primary lung cancer with cavity was 11.1%. The rate of cavitation was significantly higher in squamous cell carcinomas (p =0.024). The size of lung cancer with cavity (65 mm) was greater than lung cancer without cavity (50 mm) Mean, maximum ? (p =0.001). Median overall survival in cavitary cancers was 14 ± 2.7 months. In non-cavitary cancers, this time was 12 ± 0.8 months (p =0.887). Ot-herwise, age, gender, smoking history, cancer stage, treatment characteristics, radiometabolic properties and survival were similar in both groups (p >0.05).

Conclusion: The most common cavitation in lung cancers is seen in squamous cell cancers. Clinical, radiometabolic and survival characteristics of cavitary lung cancers are similar to those of noncavitary lung cancer.


[ Turkish ] [ Tam Metin ] [ PDF ]
[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]